跳转至内容
Merck

G001635

HPLC Analysis of 3-Methylpyrazole and 4-Methylpyrazole in Urine on Discovery® C18 after SPE using Discovery® DSC-SCX

application for SPE, application for HPLC

登录查看公司和协议定价


About This Item

技術

HPLC: suitable
solid phase extraction (SPE): suitable

測試參數

sample preparation: SPE (Solid Phase Extraction)
sample/matrix: urine spiked with 3- and 4-methylpyrazole at 1 mg/mL
SPE tube/cartridge: Discovery DSC-SCX, 500 mg/3 mL (52686-U)
condition: 2 mL methanol; 2 mL DI water
sample addition: 1 mL
washing: 2 mL DI water
elution: 2 mL 5% methanol in 250 mM potassium phosphate buffer, pH 7.4
column: Discovery C18, 15 cm × 4.6 mm, 5 μm preceded by a 2 cm guard column and 0.5 μm frit filter (504955)
mobile phase: MeOH:5 mM phosphate buffer, pH 6 (20:80)
flow rate: 1 mL/min
column temp.: 30 °C
detector: UV, 220 nm
injection: 25 μL, dilute urine extract

適合性

application for HPLC
application for SPE

應用

forensics and toxicology

法律資訊

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

分析物

说明

    3-Methylpyrazole

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门